Purpose -To investigate the value of a new cervical sonographic sign, called the jellyfish sign (JS), for predicting the risk of maternal morbidity in cases of abnormally invasive placenta (AIP) previa totalis. Materials and Methods -Retrospective evaluation of transvaginal (TV) and transabdominal (TA) scans performed in all singleton pregnancies with placenta previa totalis. JS, i.e. the absence of the normal linear demarcation between the placenta previa and the cervix, was evaluated by TV scans. The presence/severity of AIP and outcomes of maternal morbidity were related to this sign. Results -JS was noted in 8/39 (20.5%) patients. The two analyzed groups, i.e. with and without JS, were similar. The specificity of JS in AIP diagnosis, histological findings of accreta/increta/percreta, need for caesarean hysterectomy or blood loss >2000ml ranges between 92% and 96.2%, with the PPV and NPV ranging between 71.4% and 85.7% and 61.3% and 80.6%, respectively. The JS group had a significant increase in blood loss (ml) (p=0.003), transfusions (%) (p=0.016), red blood cells (p=0.002) and plasma (p=0.002), admission to an postoperative intensive care unit (ICU) (%) (p=0.002), hospitalization length (p<0.001) and the need of cesarean hysterectomy (%) (p<0.001). JS was independently correlated to cesarean hysterectomy (OR 25.6; 95% CI 2.0:322.3, p=0.012) and blood loss >2000ml (OR 16.6; 95% CI 1.5:180.1, p=0.021) also in a logistic regression model. Conclusion -JS is useful in predicting the increase in maternal morbidity: massive transfusion, admission to the ICU and cesarean hysterectomy related to intraoperative bleeding in patients with a previa AIP.

The Jellyfish Sign: A New Sonographic Cervical Marker to Predict Maternal Morbidity in Abnormally Invasive Placenta Previa / Bertucci, E.; Sileo, F. G.; Grandi, G.; Fenu, V.; Cani, C.; Mancini, L.; Mataca, E.; Facchinetti, F.. - In: ULTRASCHALL IN DER MEDIZIN. - ISSN 0172-4614. - 40:1(2017), pp. 40-46. [10.1055/s-0043-119872]

The Jellyfish Sign: A New Sonographic Cervical Marker to Predict Maternal Morbidity in Abnormally Invasive Placenta Previa

Bertucci E.;Sileo F. G.;Grandi G.;Fenu V.;Mataca E.;Facchinetti F.
2017

Abstract

Purpose -To investigate the value of a new cervical sonographic sign, called the jellyfish sign (JS), for predicting the risk of maternal morbidity in cases of abnormally invasive placenta (AIP) previa totalis. Materials and Methods -Retrospective evaluation of transvaginal (TV) and transabdominal (TA) scans performed in all singleton pregnancies with placenta previa totalis. JS, i.e. the absence of the normal linear demarcation between the placenta previa and the cervix, was evaluated by TV scans. The presence/severity of AIP and outcomes of maternal morbidity were related to this sign. Results -JS was noted in 8/39 (20.5%) patients. The two analyzed groups, i.e. with and without JS, were similar. The specificity of JS in AIP diagnosis, histological findings of accreta/increta/percreta, need for caesarean hysterectomy or blood loss >2000ml ranges between 92% and 96.2%, with the PPV and NPV ranging between 71.4% and 85.7% and 61.3% and 80.6%, respectively. The JS group had a significant increase in blood loss (ml) (p=0.003), transfusions (%) (p=0.016), red blood cells (p=0.002) and plasma (p=0.002), admission to an postoperative intensive care unit (ICU) (%) (p=0.002), hospitalization length (p<0.001) and the need of cesarean hysterectomy (%) (p<0.001). JS was independently correlated to cesarean hysterectomy (OR 25.6; 95% CI 2.0:322.3, p=0.012) and blood loss >2000ml (OR 16.6; 95% CI 1.5:180.1, p=0.021) also in a logistic regression model. Conclusion -JS is useful in predicting the increase in maternal morbidity: massive transfusion, admission to the ICU and cesarean hysterectomy related to intraoperative bleeding in patients with a previa AIP.
2017
21-nov-2017
40
1
40
46
The Jellyfish Sign: A New Sonographic Cervical Marker to Predict Maternal Morbidity in Abnormally Invasive Placenta Previa / Bertucci, E.; Sileo, F. G.; Grandi, G.; Fenu, V.; Cani, C.; Mancini, L.; Mataca, E.; Facchinetti, F.. - In: ULTRASCHALL IN DER MEDIZIN. - ISSN 0172-4614. - 40:1(2017), pp. 40-46. [10.1055/s-0043-119872]
Bertucci, E.; Sileo, F. G.; Grandi, G.; Fenu, V.; Cani, C.; Mancini, L.; Mataca, E.; Facchinetti, F.
File in questo prodotto:
File Dimensione Formato  
bertucci2017.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 383.96 kB
Formato Adobe PDF
383.96 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1201435
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 9
social impact